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ABSTRACT: Stroke is the second leading cause of death worldwide. The prognostic influence of body temperature
on acute stroke in patients has been recently reported; however, hypothermia has confounded experimental results in
animal stroke models. This work aimed to investigate how body temperature could prognose stroke severity as well
as reveal a possible mitochondrial mechanism in the association of body temperature and stroke severity.
Lipopolysaccharide (LPS) compromises mitochondrial oxidative phosphorylation in cerebrovascular endothelial cells
(CVECs) and worsens murine experimental stroke. In this study, we report that LPS (0.1 mg/kg) exacerbates stroke
infarction and neurological deficits, in the mean time LPS causes temporary hypothermia in the hyperacute stage
during 6 hours post-stroke. Lower body temperature is associated with worse infarction and higher neurological
deficit score in the LPS-stroke study. However, warming of the LPS-stroke mice compromises animal survival.
Furthermore, a high dose of LPS (2 mg/kg) worsens neurological deficits, but causes persistent severe hypothermia
that conceals the LPS exacerbation of stroke infarction. Mitochondrial respiratory chain complex I inhibitor, rotenone,
replicates the data profile of the LPS-stroke study. Moreover, we have confirmed that rotenone compromises
mitochondrial oxidative phosphorylation in CVECs. Lastly, the pooled data analyses of a large sample size (n=353)
demonstrate that stroke mice have lower body temperature compared to sham mice within 6 hours post-surgery; the
body temperature is significantly correlated with stroke outcomes; linear regression shows that lower body
temperature is significantly associated with higher neurological scores and larger infarct volume. We conclude that
post-stroke body temperature predicts stroke severity and mitochondrial impairment in CVECs plays a pivotal role
in this hypothermic response. These novel findings suggest that body temperature is prognostic for stroke severity in
experimental stroke animal models and may have translational significance for clinical stroke patients - targeting
endothelial mitochondria may be a clinically useful approach for stroke therapy.
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Stroke is the second leading cause of death and the leading
cause of disability worldwide [1]. The prognostic
influence of body temperature on acute stroke in patients
has been recently reported [2]. Animal models of ischemic
stroke are indispensable tools to investigate the
pathophysiological mechanisms involved in ischemic
brain injury and to develop novel therapies for stroke [3].

Temperature management is an important topic for
experimental animal studies in stroke. In rodents, external
warming resulted in aggravated neuronal damage
following ischemia [4], and controlled-hypothermia
robustly protects stroke outcomes after permanent and
transient cerebral ischemia [5]. However, hypothermia
has confounded experimental results in stroke [6],
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becuase it is unclear how body temperature is associated
with stroke severity in animal models of experimental
stroke, and the mechanisms are poorly understood.
Mitochondria play a pivotal role in cellular
bioenergetics and cell survival, participating in a variety
of cellular processes including generation of ATP,
maintenance of body temperature, and regulation of
apoptotic and other signaling pathways [7]. Mitochondrial
damage has been documented in ischemic stroke patients
[8, 9] and experimental stroke models [10, 11]. Our recent
study demonstrates mitochondrial dysfunction opens the
blood-brain barrier (BBB) in both in vitro and in vivo
models and controls BBB permeability in acute
experimental stroke in mice [12].
Lipopolysaccharide (LPS), a major component of
gram-negative bacteria cell wall, is broadly used as a
bacterial infection mimic to induce a systemic
inflammatory response [13]. LPS compromises
mitochondrial
oxidative
phosphorylation
in
cerebrovascular endothelial cells and worsens murine
experimental stroke [12]. High doses of LPS induce
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hypothermia [14, 15] and have been used in animal
models of sepsis [16], but the mechanism by which LPS
induces hypothermia is controversial [17].
Here, we studied LPS-exacerbated stroke and
induced hypothermia, and investigated the relationship
between body temperature and stroke outcomes in murine
experimental stroke models. Inhibition of mitochondria
with rotenone also exacerbated stroke outcomes and
induced hypothermia after transient middle cerebral artery
occlusion
(tMCAO).
Rotenone
compromised
mitochondrial oxidative phosphorylation in CVECs.
Lastly, we pooled the data analyses from a large sample
size (n=353) of body temperature and stroke outcomes
and observed a strong negative linear regression between
body temperature and stroke severity. These data suggest
body temperature is useful for prediction of stroke
severity in experimental animal stroke models and
translation of significance in clinical stroke patients and
may provide support for a clinically useful approach by
targeting endothelial mitochondria for stroke therapy.

Figure 1. Low-dose LPS causes temporary hypothermia, and the body temperature is correlated with stroke outcomes. (A)
Scheme of the experimental design. LPS (0.1 mg/kg, i.p.) or vehicle (saline, i.p.) was administered 30 min prior to right tMCAO (30
min occlusion) or sham and 48 hour reperfusion was performed. (B) Representative TTC-stained coronal sections from mice treated
with vehicle or LPS (0.1 mg/kg), followed by 30 min tMCAO and 48 hours reperfusion. (C) Neurological deficits at 6 hours after
tMCAO. Vehicle=18, LPS=23; data are expressed as mean ± S.D. ****, P<0.0001; Student’s t test. (D) Body temperature was recorded
pre-treatment (PT), pre-surgery (PS), during surgery (S) and at 6, 12, 18, 24 and 48 hours. Data are expressed as mean ± S.D.; ****,
P<0.0001; 2-way ANOVA followed by post-hoc Sidak’s multiple comparisons test. (E) Body temperature at 6 hours post-tMCAO is
correlated with % cortex, striatum, and hemisphere infarction in 14 mice of the LPS (0.1 mg/kg) cohort of stroke study. (F) Body
temperature at 6 hours post-tMCAO is correlated with neurologicial score in 41 mice of the LPS (0.1 mg/kg) cohort of stroke study.
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Figure 2. Rewarming worsens LPS-stroke mice and compromises animal survival. (A) External warming worsened neurological
deficits of LPS-tMCAO mice at 6 hours reperfusion. Room temperature (RT) n = 23, 37°C warm blanket (WB) n= 6; data are expressed
as mean ± S.D. ***, P<0.001; Student’s t test. (B) External warming compromised survival of LPS-tMCAO mice. LPS (0.1 mg/kg, ip)
was administered prior to right tMCAO (30 min occlusion). Post-stroke mice were housed at room temperature (RT, n=23) or placed
on warm blanket (37°C, n=6). Chi square was used for statistical analysis of the survival rate.

MATERIALS AND METHODS

Evaluation of neurological deficits

Mice

Neurologic deficits were determined according to a 0-5
point scale of neurological score system as published [18].
0 = no neurological dysfunction; 1 = failure to extend left
forelimb fully when lifted by tail; 2 = circling to the
contralateral side; 3 = falling to the left; 4 = no
spontaneous walk or in a comatose state; 5 = death. The
experimenters were blinded to group allocations.

All procedures conducted were approved by the
Institutional Animal Care and Use Committees (IACUC)
at the West Virginia University (WVU). Male mice with
a C57/BL6J background (3-6 months old, 25-30g,
Jackson Laboratories) were used for all studies.
Murine experimental stroke models
Surgical anesthesia was induced with 4-5% isoflurane and
maintained with 1-2% isoflurane via face-mask in
oxygen-enriched air. We performed focal cerebral
ischemia by transient middle cerebral artery occlusion
(tMCAO) or permanent middle cerebral artery occlusion
(pMCAO) with a 6.0 monofilament suture (Doccol,
Sharon, Massachusetts). We used laser Doppler
flowmetry (Moor instruments, United Kingdom) to detect
regional cerebral blood flow and confirm a successful
occlusion (>70% decrease in flow). Rectal body
temperature was maintained at 37 ±0.5 °C during surgery.
Randomized controls were used under a common protocol
that collectively assessed 353 mice, including 42 mice
with sham surgery, 40 mice with pMCAO, and 271 mice
with tMCAO. All surgeries were performed by one
surgeon who was blinded to pre-treatments. Neurological
deficits of 311 stroke mice were recorded at 6-hour, 24hour, and 48-hour end points. Infarct volume of 162 stroke
mice was determined at 24-hour or 48-hour end points
using 2,3,5-triphenyl-2H-tetrazolium chloride (TTC;
Sigma) staining.
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Drug administration
Administration of drugs by intraperitoneal (i.p.) injection
was used. The doses of LPS or rotenone were described
in Results section and figure legends.
Post-surgery temperature management
Mice were housed at room temperature (22 - 24 °C) after
stroke or sham surgery. Rectal temperature was measured
with a rectal probe thermometer (Thermoworks, Apline,
UT). External warming (37 °C warm blanket) was applied
to post-stroke mice in one study (Figure 2).
Oxygen Consumption Rate detected by Bioscience
Analyzer
Cell culture was detailed previously [12]. Oxygen
consumption rate (OCR) was measured at 37 °C using an
XF96e extracellular analyzer (Seahorse Bioscience, North
Billerica, Massachusetts) according to the manufacturer’s
instructions. Briefly, the cerebrovascular endothelial cells
(bEnd.3 cell line) were seeded into Seahorse Bioscience
XF96e cell culture plates (16,000 cells/well). After
overnight culture in the 37 °C humidified incubator with
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5% CO2, the cells were supplied with medium rotenone
(concentrations indicated in Figure 7) and cultured for
additional 24 hours. For the OCR measurements, the
medium was changed 1 h prior to the start of the
extracellular flux assay to un-buffered (pH 7.4) DMEM
containing 2 mM GlutaMax, 1 mM sodium pyruvate, and
25 mM glucose and incubated at 37°C without CO2.
Oligomycin, carbonyl cyanide 4-(trifluoromethoxy)
phenylhydrazone (FCCP), rotenone and antimycin A (all
from Sigma) of 10× compound dilutions were prepared
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for the assay. A sensor cartridge was loaded, calibrated
and equilibrated, and then the protocol was implemented
on an XF96e Analyzer. This protocol allowed
determination of the basal level of oxygen consumption,
the amount of oxygen consumption linked to ATP
production, the maximal respiration capacity, and the
non-mitochondrial oxygen consumption.

Figure 3. High-dose LPS causes persistent hypothermia, worsens neurological deficits and results in immatured
brain infarction. (A) Scheme of the experimental design. LPS (2 mg/kg, i.p.) or vehicle (saline, i.p.) was administered 30
min prior to right tMCAO (30 min occlusion) and 24 hour reperfusion was performed. (B) Neurological deficits at 24 hours
after tMCAO. N=4 per group; data are expressed as mean ± S.D. *, P<0.05; Student’s t test. (C) Representative TTCstained coronal sections from mice treated with vehicle or LPS (2 mg/kg), followed by 30 min tMCAO and 24 hours
reperfusion. Blue arrow indicated immatured infarction by TTC-staining. (D) Body temperature was recorded pre-treatment
(PT), pre-surgery (PS), during surgery (S) and at 6, 12, 18 and 24 hours. Data are expressed as mean ± S.D.; ****,
P<0.0001; 2-way ANOVA followed by post-hoc Sidak’s multiple comparisons test.
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Statistics
Comparisons of temperature were carried out by 2-way
ANOVA, followed by post-hoc Sidak’s multiple
comparison tests using Graphpad Prism software
(Graphpad software, La Jolla, California). Student’s t tests
were used in analyses of statistical differences of
neurological deficits between two groups. Comparisons
of OCR were carried out by 1-way ANOVA followed by
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post-hoc Tukey’s multiple comparison tests. Pearson’s
correlation and linear regression were used in analyses of
the relationship between body temperature and stroke
outcomes. Pearson’s r value was used to establish a
relationship: -0.01 to -0.19, no or negligible relationship;
-0.20 to -0.29, weak negative relationship; -0.30 to -0.39,
moderate negative relationship; -0.40 to -0.69, strong
negative relationship; -0.70 or higher, very strong
negative relationship. P<0.05 was considered significant.

Figure 4. Rotenone decreases body temperature dose-dependently. (A) Scheme of the experimental design. Rotenone (i.p.) or
vehicle (saline, i.p.) was administered and rectal temperature was recorded prior to treatment (PT), and at 6 and 24 hours. (B) Rotenone
decreased rectal temperature in a dose-dependent manner. Data are expressed as mean ± S.D.; *, P<0.05, ****, P<0.0001; 2-way
ANOVA followed by post-hoc Sidak’s multiple comparisons test.

RESULTS
LPS exacerbates stroke outcomes and causes prognostic
hypothermia in stroke
We have previously reported that LPS compromises
endothelial mitochondria and worsens stroke severity [12].
We applied the same study protocol as published [12] and
recorded the rectal temperature as pictured in Figure 1A.
LPS administration plus stroke exacerbated infarction
(Figure 1B) and neurological deficits at 6 hours (Figure
1C). However, we observed that rectal temperature was
significantly decreased by LPS administration plus stroke
within 6 hours after injection and partially recovered after
12 hours (Figure 1D). We then performed a correlation
analysis between body temperature and stroke outcomes.
Interestingly, there were strong negative correlations
between 6-hour body temperature and stroke outcomes
including cortical infarction (r=-0.6976, P=0.0055) and
total hemispheric infarction (r=-0.5992, P=0.0235)
(Figure 1E), and neurological score (r=-0.6564, P<0.0001)
(Figure 1F). Taken together, the data suggest that LPS
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exacerbates stroke outcomes and causes hypothermia, and
the lower body temperature is a prognostic index of worse
stroke.
It is well known that hypothermia protects stroke
outcomes after permanent or transient cerebral ischemia
[5]. To further investigate whether hypothermia worsens
or protects outcomes in the LPS-stroke study, an external
warming was applied to the LPS-stroke animals.
Surprisingly, the external warming worsened neurological
deficits (Figure 2A) and compromised survival of LPSstroke mice such that all mice died within 8 hours poststroke (Figure 2B). The data suggest that hypothermia
does protect stroke outcomes, such an observation that
seems in conflict with the observation described in Figure
1.
We have shown that LPS compromises
mitochondria in CVECs dose dependently [12]. To further
elucidate the confounding relationship between body
temperature and stroke outcomes, a high dose of LPS (2
mg/kg) that induces hypothermia in mice [14, 15] was
applied to mice following the protocol depicted in Figure
3A. Interestingly, a high dose of LPS plus tMCAO
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worsened neurological deficits (Figure 3B) but caused
immatured stroke infarction, which showed pink staining
using TTC (Figure 3C), and resulted in persistent severe
hypothermia after tMCAO (Figure 3D). The data indicate

Hypothermia, Mitochondria and Stroke
that a high dose of LPS worsens stroke neurological
deficits and leads to persistent severe hypothermia, which
protects stroke infarction.

Figure. 5. Low-dose rotenone causes hypothermia, and body temperature is correlated with acute stroke outcomes in mice. (A)
Scheme of the experimental design. Rotenone (1 mg/kg, i.p.) or vehicle (saline, i.p.) was administered 30 min prior to right tMCAO
(60 min occlusion) and 24 hour reperfusion was performed. (B) Representative TTC-stained coronal sections from mice treated with
vehicle or rotenone (1 mg/kg), followed by 60 min tMCAO and 24 hours reperfusion. (C) Neurological deficits at 24 hours after
tMCAO. N=12 per group; data are expressed as mean ± S.D. ****, P<0.0001; Student’s t test. (D) Body temperature was recorded
pre-treatment (PT), pre-surgery (PS), during surgery (S) and at 6 and 24 hours. Data are expressed as mean ± S.D.; ****, P<0.0001;
2-way ANOVA followed by post-hoc Sidak’s multiple comparisons test. (E) Body temperature is correlated with neurologicial score
in 24 mice of rotenone (1 mg/kg) cohort of stroke study. (F) Body temperature is correlated with % cortex infarction, striatum
infarction, and hemisphere infarction in 16 mice in the rotenone (1 mg/kg) cohort of stroke study.

Mitochondrial
impairment
in
cerebrovascular
endothelial cells is involved in post-stroke hypothermia
Due to the key role of mitochondria in cellular
bioenergetics and metabolisms, low body temperature has
been considered a symptom of mitochondrial failure [19].
LPS impairs mitochondrial oxidative phosphorylation [12]
and causes hypothermia (Figure 1 and 3). To further
elucidate
whether
mitochondrial
oxidative
phosphorylation is involved in the body temperature
change in acute stroke, we treated mice with rotenone (a
mitochondrial respiratory chain complex I inhibitor) and
monitored rectal temperature (Figure 4A). Rotenone
alone dose-dependently decreased body temperature in
vivo (Figure 4B). In a study of the combination of
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rotenone and stroke, a low dose of rotenone (1 mg/kg),
which did not induce hypothermia in naive mice (Figure
4), exacerbated infarction (Figure 5B), worsened
neurological deficits (Figure 5C), as well as resulted in
significant hypothermia following 60 min tMCAO
(Figure 5C). Correlational analysis showed very strong
negative correlations between 6-hour body temperature
and neurological score (r=-0.7452, P<0.0001, Figure 5E),
cortical infarction (r=-0.7368, P=0.0011) and hemisphere
infarction (r=-0.8213, P<0.0001), and strong negative
correlations with striatum infarction (r=-0.6633,
P=0.0051) (Figure 5F). These data are consistent with the
findings in the low dose LPS-stroke study (Figure 1) and
suggest that mitochondrial impairment is involved in the
body temperature change in stroke.
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Figure 6. High-dose rotenone causes persistent hypothermia, worsens neurological deficits, and results
in immatured brain infarction. (A) Scheme of the experimental design. Rotenone (4 mg/kg, i.p.) or vehicle
(saline, i.p.) was administered 30 min prior to right tMCAO (30 min occlusion) and 24 hour reperfusion was
performed. (B) Neurological deficits at 24 hours after tMCAO. N=4 per group; data are expressed as mean ±
S.D. **, P<0.01; Student’s t test. (C) Representative TTC-stained coronal sections from mice treated with
vehicle or rotenone (4 mg/kg), followed by 30 min tMCAO and 24 hours reperfusion. Blue arrow indicates
immature infarction from TTC staining. (D) Rectal temperature was recorded pre-treatment (PT), pre-surgery
(PS), during surgery (S) and at 6 and 24 hours. Data are expressed as mean ± S.D.; ****, P<0.0001, ***,
P<0.001; 2-way ANOVA followed by post-hoc Sidak’s multiple comparisons test.
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Figure 7. Rotenone compromises mitochondrial function in cultured cerebral vascular endothelial cells. (A) Raw data of oxgen
consumption rate (OCR) determinied by the Seahorse XF96e analyzer. Cultured cerebral vascular endothelial cells (bEnd3. cell line)
were incubated with various concentration of rotenone for 24 hours then OCR was determined upon sequential exposure to oligomycin,
FCCP, and rotenone/antimycin. (B) Analysis of the Seahorse data. Rotenone decreased basal respiration, oligomycin-sensitive ATP
production, maximal respiration in the presence of FCCP, and spare capacity of cerebral vascular endothelial cells in a dose-dependent
manner. N = 4 per group; *, P<0.05; **, P<0.01; ***, P<0.001; ****, P<0.0001. One-way ANOVA followed by post-hoc Tukey’s
test was used for statistical analysis.

Interestingly, a high dose of rotenone (4 mg/kg),
which induces hypothermia in naive mice (Figure 4),
worsened neurological deficits following 30 min tMCAO
(Figure 6B) but resulted in immatured stroke infarction by
TTC-staining (Figure 6C) and also caused persistent
severe hypothermia (Figure 6D), which replicated the
results from the high dose of LPS plus tMCAO mice
(Figure 3). Again, the data indicate that a high dose of
rotenone worsens stroke neurological deficits and results
in persistent severe hypothermia that is protective for
stroke infarction.
In order to identify whether rotenone affects
cerebrovascular endothelial mitochondria, such as that
LPS targets on CVECs in our previous report [12], a
cerebrovascular endothelial cell culture model was
employed and mitochondrial capacity was evaluated. We
found that rotenone dose-dependently compromised
mitochondrial oxidative phosphorylation in CVECs
(Figure 7). Mitochondrial basal respiration, ATP
production, maximal respiration, and spare capacity were
all reduced in CVECs (Figure 7B). These data suggest
that CVECs are one of the cellular targets in the
mitochondrial impairment.
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Body temperature predicts stroke outcomes
To further investigate the relationships between body
temperature and stroke outcomes, we pooled the data from
353 mice, with 42 (11.9%) sham surgery, 271 (76.8%)
tMCAO, 40 (11.3%) pMCAO on stroke outcomes. Before
surgery, there was no significant difference between the
body temperatures of treatment groups (Figure 8A).
Stroke mice had lower body temperature compared to
sham mice within 6 hours post-surgery (Figure 8A). We
performed the correlation analyses and linear regression
analyses respectively to address the relationship of
neurological score and infarct volumes with rectal
temperature recorded within 6 hours post-surgery. There
were significant negative correlations between 6 hours
post-surgery body temperature and neurological deficits,
and all infarct volumes (cortex, striatum, or total
hemisphere) after MCAO (Figure 8B and C). Linear
regression with neurological score as the dependent
variable showed that lower body temperature was
significantly associated with higher neurological score at
all end points (r=-0.5432, R2=0.2951, P<0.0001, Figure
8B). Linear regression also showed significant
associations between lower body temperature and larger
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cortex infarct volume (r=-0.3476, R2=0.1208, P<0.0001),
striatum infarct volume (r=-0.2782, R2 =0.07741,
P=0.0003), and total hemisphere infarct volume (r=0.4124, R2=0.1701, P<0.0001) (Figure 8C). These data

Hypothermia, Mitochondria and Stroke
suggest that hypothermia is a common response to stroke
and predicts worse stroke outcomes in murine
experimental stroke.

Figure 8. The relationship of body temperature and stroke outcomes in murine experimental stroke. (A) Stroke decreased
body temperature. Rectal temperature was recorded pre-surgery (PS), during surgery (S), and within 6 hours post-surgery. Data are
presented as mean ± S.D.; 2-way ANOVA followed by post-hoc Sidak's multiple comparisons test. ****, P<0.0001. (B) Body
temperature is correlated with neurological score in 311 mice. (C) Body temperature is correlated with % cortex infarction, striatum
infarction, and hemisphere infarction in 162 mice.

DISCUSSION
In this study, we investigated the relationship between
body temperature and stroke outcomes in experimental
stroke and revealed a mitochondrial mechanism in the
hypothermic response to stroke. As summarized in Figure
9, stroke, LPS, or rotenone causes endothelial
mitochondria impairment in the acute stage, which
increases BBB permeability and brain edema, then
worsens stroke outcomes. However, compromised
endothelial mitochondria also lead to hypothermia, which
delays neuronal death and protects stroke infarction, and
thus conceals some of the negative effects in stroke.
Therefore, hypothermia is indicative of mitochondrial
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impairment in BBB endothelium and can be used to
predict stroke severity in mice.
Body temperature is one of the vital signs in
monitoring medical problems. Recent clinical studies
demonstrate that low body temperature within 6 hours of
symptom onset is associated with severe ischemic stroke
[2, 20] and severe stroke subjects have relatively low body
temperatures at admission within 12 hours of symptom
onset in human subjects [21]. In animal models of
experimental stroke, it is well known that controlledhypothermia is a neuroprotectant and a potential treatment
in cerebral ischemia via reduction of energy requirements
in the brain and protect the brain from infarct formation
[22, 23]. Barber et al. [24] observed that temperature in
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mouse MCAO is important to stoke outcomes. Our data
demonstrate a decrease in body temperature within 6
hours in experimental stroke (Figure 8). Not only did
LPS- or rotenone-pretreatments reduce body temperature
in experimental stroke (Fig.1D, 3D, 5D and 6D), but also
in naive mice, high doses of LPS or rotenone induced

Hypothermia, Mitochondria and Stroke
hypothermic responses within hours (Figure 3D and 4B).
Thus, body temperature alterations may reveal previously
unknown mechanism factors that contribute to stroke
severity.

Figure 9. Endothelial mitochondria and hypothermia are engaged in stroke outcomes. Stroke, LPS or rotenone compromises
endothelial mitochondria in the acute stage. The mitochondrial impairment increases BBB permeability and brain edema, further
worsens stroke outcomes. The mitochondrial impairment also leads to hypothermia, which is neuroprotective and protects stroke
outcomes. Hypothermia is indicative of the mitochondrial capacity and therefore has prognostic effect on stroke outcomes.
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It is known that mitochondrial oxidative metabolism
is one of the homeostatic mechanisms used to generate
heat for maintenance of body temperature. However, the
thermoregulation is far more complex. Briefly, the
vascular endothelium, smooth muscle cells, and nerve
terminals form an integrated unit and regulate body
temperature by preserving or releasing heat generated by
mitochondrial activity in periphery and are coordinated by
hypothalamus in central nervous system (CNS) [25].
Undoubtedly, the endothelium plays an important role in
maintaining and regulating body temperature. Given the
extensive expression of TLR4 (LPS receptor) on
endothelial cells, hypothermia induced by high dose of
LPS in sepsis model [26] or low dose of LPS plus tMCAO
(Figure 1) may be due to compromised mitochondrial
function in endothelial cells [12]. Rotenone decreased
body temperature dose-dependently (Figure 4),
compromised mitochondrial oxidative phosphorylation in
cerebrovascular endothelial cells in vitro (Figure 3) and
increased BBB permeability [12]. The observation of
hypothermia in LPS-stroke mice (Figure 1 and 3) and
rotenone-stroke mice (Figure 5 and 6), consistent with the
temporal profile of BBB leakage at 6 hours post-stroke,
indicates that compromised mitochondrial capacity in
endothelium may not be able to maintain BBB integrity
and normal body temperature, resulting in elevated BBB
leakage
and
post-stroke
hypothermia.
Thus,
mitochondrial mechanism may be one of the important
factors of the hypothermic response to stroke. The data
also suggest that the hypothermic response in severe cases
of sepsis in animal studies and clinically may also be
mitochondrial-dependent.
It was observed that low doses of rotenone or LPS,
which did not significantly alter body temperature in sham
or naive mice (Figure 1D and Figure 4), caused robust
hypothermia and exacerbated stroke outcomes (Figure 1D
and 5D). Both LPS [12] and rotenone (Figure 7) impair
endothelial mitochondria. Stroke induces mitochondrial
failure and causes cell death [27]. The low dose of LPSor rotenone may interact with stroke to further impair
mitochondrial function and exacerbate stroke outcomes.
It is well-known that hypothermia protects the brain
from deleterious ischemic effects and our data also
confirmed its neuroprotective effect in stroke. We found
that external warming compromised survival of the
hypothermic LPS-tMCAO mice (Figure 2). High doses of
LPS (2 mg/kg, Figure 3) or rotenone (4 mg/kg, Figure 6)
could be very toxic to brain tissue, while LPS- or
rotenone-induced neurotoxicity is seen with local
administration [28, 29]; however, large infarctions were
not observed following the combination of high doses of
LPS or rotenone and tMCAO. The observed hypothermia
may have protected the brain by reducing the energy and
oxygen demand of brain tissue and delayed cell death in
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the ischemic area. Functional outcomes demonstrate
sensitive or earlier indication than pathological cell death,
and thus, the worse neurological deficits, rather than the
stroke infarction, were observed in severe hypothermic
animals (Figure 3B and 6B).
Interestingly, persistent post-stroke hypothermia
resulted in immatured stroke infarction in the ischemic
brain by TTC-staining and worse neurological deficits
(Figure 3 and 6). These findings have been supported by
other laboratories. Denes et al. [30] reported that LPS
compromised survival and increased brain edema but not
infarct size as assessed by crystal-violet staining; Moyer
et al. [31] reported hypothermia during occlusion
diminishes cerebral infarction in rats. Several groups have
reported that NBQX (2,3-dihydroxy-6-nitro-7-sulfamoylbenzo (F)quinoxaline), an α-amino-3-hydroxy-5-methyl4-isoxazole propionate antagonist, provides robust
protection against neuronal loss in experimental stroke
models [32-35]. However, Nurse and Corbett [36] have
further verified that a hypothermic action is linearly
related to the neuroprotective efficacy and NBQX is
ineffective against cerebral ischemia when the body
temperature was regulated to mimic that of the vehicle
group. Taken together, the hypothermic response protects
stroke infarction and may lead to false negative data in
quantifying infarct size in experimental animal stroke
studies. The false negative data could be reversed by
extension of endpoints (Figure 1), lowering the dose of
drugs (Figure 1 and 5), or inducing a larger injury (Figure
5). Therefore, caution should be taken in the conclusion
of infarct size changes using animal models of
experimental stroke.
Another important finding was the negative
correlations between body temperature and stroke
outcomes. In Figure 1, 5 and 8, the strong associations
support that hypothermic animals have higher
neurological deficits and larger infarction. The significant
linear regression (Figure 8) indicates that stroke outcomes
may be determined by body temperatures early after
strokes. Even though the data were from pooled analyses,
which might be affected by multiple factors, it does
suggest that body temperatures may predict stroke
outcomes. The mitochondria-dependent hypothermic
response explains the correlation of hypothermia and
stroke severity in vivo and the doubling of mortality rate
in hypothermic sepsis patients [37]. In both disease states,
induced hypothermia is thought to be protective; however,
if hypothermia is a result of brain endothelial cell
mitochondrial dysfunction, the association of
hypothermia and exacerbated disease outcomes is not
surprising because severe hypothermia indicates worse
mitochondrial impairment in endothelium as described in
Figure 9. These findings offer early clues on
mitochondrial impairment in stroke and sepsis and offer a
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translational significance in that mitochondrial protection
could be used.
The involvement of hypothalamic damage in poststroke thermoregulation has been reported [38]. In our
study, only a few MCAO mice had visible hypothalamic
injury (by TTC staining) with or without severe brain
edema. In these few cases, injury to the hypothalamus
may be caused by occlusion of hypothalamus arterial
perforators, but also could be due to brain edema caused
by BBB leakage. In view of the correlation between
hypothermia and infarct volume as well as the rare
occurrences of hypothalamic injury, we argue that the
hypothermic response is due to mitochondrial impairment
rather than the hypothalamic damage.
LPS [39, 40] and rotenone [41, 42] are well-known
to induce systemic hemodynamic alterations. LPS may
reduce interendothelial coupling and arteriolar conduction
and cause hemodynamic effects [43]. Rounds and
McMurtry [44] demonstrated that inhibition of ATP
production by rotenone decreases vasoconstriction,
blocks subsequent pressor responses, and causes
hemodynamic effects. Our data demonstrated that LPS
[12] or rotenone (Figure 7) compromises endothelial
mitochondrial oxidative phosphorylation. Mitochondria
by themselves generate reactive oxidative species (ROS)
during normal respiration, and some studies suggest that
when the normal function of the electron transport chain
is affected, ROS output may be augmented, thus
increasing the oxidative burden of the cell and inhibit
pressor responses [45, 46]. The hemodynamic effects
could result from the compromised endothelial
mitochondria and can potentially lead to body temperature
decrease as well as worsen stroke outcomes. The
hemodynamic responses could also be secondary effects
resulting from the compromised mitochondria in line with
previous report [47], and probably is indicative of stroke
severity as well.
Our study has several limitations. First, only young
male mice and ischemic stroke models were used. Second,
our stroke models produced large infarcts that more
closely resemble malignant infarction than the average
size of human strokes [48]. Third, we did not monitor
post-stroke decline in spontaneous locomotor activity,
which may affect body temperature. Addition of other
species, multiple strains, different ages, both genders and
multiple types of experimental stroke models along with
long-term functional recovery are needed to firmly
establish the relationship between post-stroke body
temperature alterations and stroke outcomes.
In summary, this study demonstrates a negative
correlation between body temperature and stroke severity
in animal models of experimental stroke, elucidates a new
mitochondrial-dependent mechanism for hypothermic
response in stroke, and suggests the need to protect
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endothelial mitochondria for stroke patients with
hypothermia.
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